Showing results (141-150 of 159) with videos related to
Sort By:
Pageof 16
Schweizerische Medizinische Wochenschrift|February 11, 1995
[Participation in multicenter studies as quality control in the therapy of Hodgkin disease: an interim report]A Lohri, S Leyvraz, T Cerny, et al.Molecular Genetics and Genomics : MGG|March 12, 2004
Horizontal gene transfer promoted evolution of the ability to propagate under anaerobic conditions in yeastsZ Gojković, W Knecht, E Zameitat, et al.Medizinische Klinik (Munich, Germany : 1983)|November 15, 1992
[Recurrence of Hodgkin's disease after advanced primary stages. German Hodgkin's Study Group]R Fuchs, M Löffler, M Pfreundschuh, et al.Leukemia & Lymphoma|June 1, 1994
Prognosis of high dose chemotherapy/autologous bone marrow transplantation candidates not receiving this treatment after failure of primary therapy of Hodgkin's diseaseR Fuchs, M Löffler, M Pfreundschuh, et al.The Journal of Pharmacology and Experimental Therapeutics|July 1, 1994
Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonistM Clozel, V Breu, G A Gray, et al.Nature|October 21, 1993
Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonistM Clozel, V Breu, K Burri, et al.Deutsche Medizinische Wochenschrift (1946)|June 26, 1992
[Fluorouracil as monotherapy or combined with folinic acid in the treatment of metastasizing colorectal carcinoma]T M Löffler, F W Korsten, H E Reis, et al.Current Genetics|February 5, 1999
GRC5 and NMD3 function in translational control of gene expression and interact geneticallyT Karl, K Onder, R Kodzius, et al.Neuroscience|July 3, 1999
Endothelin B receptor-deficient rats as a subtraction model to study the cerebral endothelin systemH Ehrenreich, J Oldenburg, M Hasselblatt, et al.Oncogene|December 12, 1997
p53-induced apoptosis in the human T-ALL cell line CCRF-CEMS Geley, B L Hartmann, R Hattmannstorfer, et al.Pageof 16